论文部分内容阅读
目的单硝酸异山梨酯治疗冠心病心功能不全的临床价值,分析提升冠心病心功能不全患者预后水平的临床方法。方法选择本院2013年7月-2015年7月接收的冠心病心功能不全患者200例,随机分为试验组和对照组各100例,试验组采取单硝酸异山梨酯治疗;对照组采用硝酸异山梨酯治疗,对2组入选患者的临床效果进行客观对比,并评定患者心绞痛症状发作次数。结果试验组总有效率为95.00%明显高于对照组的80.00%(P<0.05);试验组出现心绞痛症状发作症状1例(1.00%)低于对照组的16例(16.00%),差异有统计学意义(P<0.05)。结论在冠心病心功能不全患者中推行单硝酸异山梨酯治疗方案可以取得显著疗效,不仅可以提升患者有效率,还能够避免心绞痛症状发作,值得推广。
Objective To evaluate the clinical value of isosorbide mononitrate in the treatment of cardiac dysfunction in patients with coronary heart disease and to analyze the clinical methods to improve the prognosis of patients with coronary heart disease and cardiac dysfunction. Methods 200 patients with CHD who received coronary heart disease from July 2013 to July 2015 in our hospital were randomly divided into experimental group and control group with 100 cases in each group. The experimental group was treated with isosorbide mononitrate. The control group was treated with nitric acid Isosorbide treatment, objective evaluation of the clinical effects of the two groups of patients selected, and assess the number of patients with angina attacks. Results The total effective rate in the experimental group was 95.00%, which was significantly higher than that in the control group (80.00%, P <0.05). One case (1.00%) of the experimental group had lower incidence of angina pectoris than 16 cases (16.00%) of the control group, Statistical significance (P <0.05). Conclusions The implementation of isosorbide mononitrate in patients with CHD can achieve a significant effect, which can not only improve the efficiency of patients but also prevent the onset of angina pectoris, which is worthy of popularization.